Clinical Factors Associated With Non-Completion of Durvalumab Maintenance Therapy After Chemoradiotherapy in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Single-Center Retrospective Study.

Thorac Cancer · 2026 · PMC13279546 · PMID 42316436

Europe PMC DOI

hedged sentences

0.0680

closest p · 1.4× alpha

0.0760

boldest claim

The sentences

did not reach statistical significancep = 0.068so close (0.05 < p ≤ 0.1)

For RDW‐SD, the difference in OS was statistically significant ( p = 0.004), whereas the difference in PFS did not reach statistical significance ( p = 0.068), despite a numerical difference in median PFS (24.8 vs. 9.1 months).

also in 111,027 other papers

showed a trendp = 0.076so close (0.05 < p ≤ 0.1)

RDW‐SD showed a trend toward an inverse association with completion (OR, 0.942; 95% CI, 0.883–1.01; p = 0.076).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.